Serena Calamaio
Papers
1
Total Citations
7
H-Index
1
About
Dr. Serena Calamaio stands at the forefront of cardiac electrophysiology, pioneering the integration of automated patch-clamp technology with induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) to unravel the mysteries of Brugada Syndrome. Her landmark 2023 paper, which has already garnered 7 citations, represents a paradigm shift in arrhythmia research by demonstrating how high-throughput electrophysiological screening can overcome the traditional limitations of studying this life-threatening heart disorder. By developing a synergistic platform that combines the scalability of automated patch-clamp with the patient-specific relevance of iPSC-CMs, Calamaio has created a powerful tool for dissecting the cellular mechanisms underlying abnormal electrocardiographic readings and sudden cardiac death risk. Her work not only accelerates the identification of arrhythmogenic substrates but also establishes a new gold standard for drug testing and personalized medicine in cardiac channelopathies. This methodological breakthrough promises to transform how researchers investigate Brugada syndrome, moving from low-yield manual techniques to reproducible, high-content analysis that can simultaneously evaluate multiple ion channel targets. Calamaio’s contributions are already shaping the next generation of cardiac safety pharmacology and precision therapeutics.
Research Focus
Key Achievements
Top Papers
- 1